1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Monica Bhatia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| R-MVST Cells for Treatment of Viral Infections in Children and Young Adults Rapidly generated virus specific T (R-MVST) cells - Epstein-Barr Virus, Cytomegalovirus Infections | Phase 1 | Recruiting | Monica Bhatia | 18 | 2025-04-20 | 2026-07-30 |
| Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease Diphenhydramine, Acetaminophen, Methylprednisolone - Sickle Cell Disease, Graft Versus Host Disease | Phase 1 | Completed | Monica Bhatia | 24 | 2016-07-01 | 2024-06-13 |
Adenoviridae Infections (1) · Anemia, Sickle Cell (1) · Cytomegalovirus Infections (1) · Epstein-Barr Virus Infections (1) · Graft vs Host Disease (1) · Immunologic Deficiency Syndromes (1)
Abatacept (1) · Acetaminophen (1) · Alemtuzumab (1) · Cell Count (1) · Cyclosporine (1) · Diphenhydramine (1) · Melphalan (1) · Meperidine (1) · Methotrexate (1) · Methylprednisolone (1) · Mycophenolic Acid (1) · Sirolimus (1) · Stem Cell Transplantation (1) · Tacrolimus (1) · Thiotepa (1)
United States (2)